Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Oct;21(10):1211-7.
doi: 10.1007/s00192-010-1181-6. Epub 2010 May 26.

Efficacy and safety of TVT-O and TVT-Secur in the treatment of female stress urinary incontinence: 1-year follow-up

Affiliations
Randomized Controlled Trial

Efficacy and safety of TVT-O and TVT-Secur in the treatment of female stress urinary incontinence: 1-year follow-up

Giovanni A Tommaselli et al. Int Urogynecol J. 2010 Oct.

Abstract

Introduction and hypothesis: To reduce complications of transobturator tension-free vaginal tape, single-incision devices were introduced in the last years. We here report a comparison between the tension-free vaginal tape-obturator (TVT-O) and the TVT-Secur techniques in terms of efficacy and safety.

Methods: Eighty-four patients with stress urinary incontinence (SUI) were scheduled to undergo TVT-O or TVT-Secur. Duration of the procedure, subjective estimate of blood loss, intraoperative and postoperative complications, postoperative postvoidal residue (PVR), time to first voiding, and pain level were recorded. Urodynamic tests, PVR, Incontinence Questionnaire Short Form (ICIQ-SF), King's Health Questionnaire, and a urinary diary were performed before and 12 months after procedure.

Results: No differences in terms of cure rate were observed between the two groups (81.6% vs. 83.8%). Complication rate in the TVT-Secur group was lower (8.1%) than in the TVT-O group (15.8%), but not significant.

Conclusions: Both techniques seem to be effective and safe, with a low incidence of complications in both groups.

PubMed Disclaimer

References

    1. Eur Urol. 2004 Nov;46(5):675; author reply 675-6 - PubMed
    1. Health Technol Assess. 2003;7(21):iii, 1-189 - PubMed
    1. BJU Int. 2009 Jul;104(2):225-8 - PubMed
    1. Br J Obstet Gynaecol. 1997 Dec;104(12):1374-9 - PubMed
    1. Gynecol Obstet Invest. 1999;48(4):267-9 - PubMed

Publication types

LinkOut - more resources